Neonatal outcome after treatment with ritodrine: a controlled study.
Neonatal condition was assessed in a group of 82 infants born at term after maternal treatment with ritodrine for an average of 28.5 days, and compared with that in a matched control group of infants. No statistically significant differences were found in umbilical pH, Apgar scores, head circumference, and neurological condition. Although the difference was not statistically significant, doubt remains as to a possible icterogenic effect of ritodrine.
D000328:Adult; D001034:Apgar Score; D002508:Cephalometry; D005260:Female; D005312:Fetal Blood; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000139:chemically induced*; D008431:Maternal-Fetal Exchange; D009460:Neurologic Examination; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D011412:Propanolamines / Q000009:adverse effects*; D012312:Ritodrine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D011412:Propanolamines; D012312:Ritodrine